Carregant...

Thrombolytic therapy for pulmonary embolism

BACKGROUND: Thrombolytic therapy is usually reserved for people with clinically serious or massive pulmonary embolism (PE). Evidence suggests that thrombolytic agents may dissolve blood clots more rapidly than heparin and may reduce the death rate associated with PE. However, there are still concern...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cochrane Database Syst Rev
Autors principals: Zuo, Zhiliang, Yue, Jirong, Dong, Bi Rong, Wu, Taixiang, Liu, Guan J, Hao, Qiukui
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Ltd 2021
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8092433/
https://ncbi.nlm.nih.gov/pubmed/33857326
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD004437.pub6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!